Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Medical Teacher
|
April 15, 2016
Twelve tips for medical students to facilitate a Photovoice project
Deep Jaiswal, Matthew J To, Heather Hunter, et al.
BMJ Open
|
September 26, 2014
Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Evangelia-Ourania Fourkala, Matthew Burnell, Catherine Cox, et al.
Plos One
|
June 30, 2015
Bisexual Behaviors, HIV Knowledge, and Stigmatizing/Discriminatory Attitudes among Men Who Have Sex with Men
Meizhen Liao, Mei Wang, Xingjie Shen, et al.
Biomed Research International
|
February 28, 2014
Changing the landscape of the HIV epidemic among MSM in China: results from three consecutive respondent-driven sampling surveys from 2009 to 2011
Xuefeng Li, Hongyan Lu, Catherine Cox, et al.
BMC Public Health
|
February 19, 2014
Syndemics of syphilis, HCV infection, and methamphetamine use along the east coast of China
Meizhen Liao, Dianmin Kang, Xiaorun Tao, et al.
Vaccine
|
January 26, 2021
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing
DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Journal of Immunological Methods
|
September 13, 2003
Optimization of methods to assess human mucosal T-cell responses to HIV infection
Barbara L Shacklett, Otto Yang, Mary Ann Hausner, et al.
NPJ Vaccines
|
November 24, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine
Lisa A Jackson, Rhea N Coler, Gregory A Deye, et al.
The Journal of Infectious Diseases
|
February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge
DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Science Translational Medicine
|
December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Medical Teacher
|
April 15, 2016
Twelve tips for medical students to facilitate a Photovoice project
Deep Jaiswal, Matthew J To, Heather Hunter, et al.
BMJ Open
|
September 26, 2014
Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Evangelia-Ourania Fourkala, Matthew Burnell, Catherine Cox, et al.
Plos One
|
June 30, 2015
Bisexual Behaviors, HIV Knowledge, and Stigmatizing/Discriminatory Attitudes among Men Who Have Sex with Men
Meizhen Liao, Mei Wang, Xingjie Shen, et al.
Biomed Research International
|
February 28, 2014
Changing the landscape of the HIV epidemic among MSM in China: results from three consecutive respondent-driven sampling surveys from 2009 to 2011
Xuefeng Li, Hongyan Lu, Catherine Cox, et al.
BMC Public Health
|
February 19, 2014
Syndemics of syphilis, HCV infection, and methamphetamine use along the east coast of China
Meizhen Liao, Dianmin Kang, Xiaorun Tao, et al.
Vaccine
|
January 26, 2021
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing
DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Journal of Immunological Methods
|
September 13, 2003
Optimization of methods to assess human mucosal T-cell responses to HIV infection
Barbara L Shacklett, Otto Yang, Mary Ann Hausner, et al.
NPJ Vaccines
|
November 24, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine
Lisa A Jackson, Rhea N Coler, Gregory A Deye, et al.
The Journal of Infectious Diseases
|
February 8, 2024
Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge
DeAnna J Friedman-Klabanoff, Andrea A Berry, Mark A Travassos, et al.
Science Translational Medicine
|
December 8, 2022
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
Sodiomon B Sirima, Alphonse Ouédraogo, Alfred B Tiono, et al.
Page
of 4